China Universal Asset Management Company’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $777K | Buy |
15,918
+98
| +0.6% | +$4.79K | 0.07% | 198 |
|
|
2025
Q1 | $806K | Sell |
15,820
-533
| -3% | -$27.2K | 0.08% | 207 |
|
|
2024
Q4 | $738K | Buy |
16,353
+1,558
| +11% | +$70.3K | 0.07% | 200 |
|
|
2024
Q3 | $549K | Buy |
14,795
+5,783
| +64% | +$215K | 0.06% | 203 |
|
|
2024
Q2 | $276K | Sell |
9,012
-5,740
| -39% | -$176K | 0.04% | 200 |
|
|
2024
Q1 | $429K | Buy |
14,752
+6,025
| +69% | +$175K | 0.05% | 198 |
|
|
2023
Q4 | $241K | Buy |
8,727
+6,786
| +350% | +$187K | 0.05% | 190 |
|
|
2023
Q3 | $43.5K | Buy |
1,941
+969
| +100% | +$21.7K | 0.01% | 236 |
|
|
2023
Q2 | $39.5K | Sell |
972
-28
| -3% | -$1.14K | 0.01% | 215 |
|
|
2023
Q1 | $48.4K | Buy |
1,000
+269
| +37% | +$13K | 0.02% | 152 |
|
|
2022
Q4 | $27.9K | Buy |
731
+61
| +9% | +$2.33K | 0.01% | 157 |
|
|
2022
Q3 | $34K | Buy |
+670
| New | +$34K | 0.01% | 136 |
|